Malaria Treatment May Be Found by Targeting the Host
Potential Delay in Filing for Approval of Reata Pharmaceuticals’ FA Drug
Novavax Rises 5% On Earnings; $2B Covid-19 Vaccine Funding
Novo Nordisk: Prevention, digital tools and collaboration to define the future of diabetes
Gilead Submits New Drug Application With FDA For Remdesivir
Agtech to the rescue in a pandemic: adapting plant labs for human testing
PTC Therapeutics Scores Early FDA Nod For Evrysdi; Analyst Stays Sidelined
Sophia Genetics launches AI tool to find COVID-19 ‘unknowns’
Locking down shape-shifting spike protein aids development of COVID-19 vaccine
Study suggests embryos could be susceptible to coronavirus
NIH funds Dartmouth and Tufts AI tool to help doctors cure cancer
WHO Conducted "Extensive Interviews" With Wuhan Scientists Amid Efforts To Prove Virus Didn't Escape Lab
Global COVID-19 Spread Slowest In 3 Weeks As Deaths Near 700,000: Live Updates
Yes, PCR tests can detect “the COVID virus”
COVID-19: Lower incidence at high altitudes?
Researchers uncovered the Zika virus mutation responsible for quick spread, birth defects
Monte Carlo Simulations to Democratize COVID-19 Policies*
Overcoming Scale-Up Challenges in Gene Therapy Manufacturing
CRISPR Startups Give Genome Editing Several New Twists
Fully Automated Luxury Drug Discovery
Vaccine Hunt: Is Injecting Human Volunteers With COVID-19 Ethical?
Vaccine Effectiveness Could be Boosted in the Elderly
Malaria Transport Channel Identified Connecting Parasite to Red Blood Cell
Does coronavirus linger in the body? What we know about how viruses in general hang on in the brain and testicles
Researchers describe structure of SARS-CoV-2 proteins suitable for design of new drugs
Massachusetts Biopharma Industry Weathers COVID-19 Impacts on Jobs, Financing
Coronavirus infectiousness wanes by day 9; long ICU stays linked with nerve damage
Mass. Biopharma Industry Weathers COVID-19 Impacts on Jobs, Financing
Using population health analysis to improve patient care brings Sema4 a $1.1 billion valuation
Computational gene study suggests new pathway for COVID-19 inflammatory response